TIBER CREEK GROUP for MERCK & CO., INC
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Trade (domestic/foreign) TRD
Issues related to the United States-Mexico-Canada-Agreement (USMCA)
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MICHAEL GONZALEZ | — |
Health Issues HCR
Issues related to pharmaceutical pricing and transparency. S. 2543 - The Prescription Drug Price Reduction Act. H.R. 3 - Lower Drug Costs Now Act of 2019. H.R.1865 Further Consolidated Appropriations Act, 2020 (Public Law No: 116-94)
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MICHAEL GONZALEZ | — |
| JONATHON JONES | — |
| ANDREW MCKECHNIE | — |
Medicare/Medicaid MMM
Issues relating to pharmaceutical pricing and transparency. Provisions relating to Part D Pricing Reform. Proposal to eliminate Medicaid inflationary cap. Issues relating to biosimilars coverage & pricing. S. 2543 - The Prescription Drug Price Reduction Act. H.R. 3 - Lower Drug Costs Now Act of 2019. H.R.1865 Further Consolidated Appropriations Act, 2020 (Public Law No: 116-94)
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MICHAEL GONZALEZ | — |
| JONATHON JONES | — |
| ANDREW MCKECHNIE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.